Potential Drug Interactions of Repurposed COVID-19 Drugs with Lung Cancer Pharmacotherapies

Lung cancer patients are at heightened risk for developing COVID-19 infection as well as complications due to multiple risk factors such as underlying malignancy, anti-cancer treatment induced immunosuppression, additional comorbidities and history of smoking. Recent literatures have reported a sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Baburaj, Gayathri, Thomas, Levin, Rao, Mahadev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IMSS. Published by Elsevier Inc. 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670900/
https://www.ncbi.nlm.nih.gov/pubmed/33257051
http://dx.doi.org/10.1016/j.arcmed.2020.11.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670900/
https://www.ncbi.nlm.nih.gov/pubmed/33257051
http://dx.doi.org/10.1016/j.arcmed.2020.11.006

Ejemplares similares